Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suhuang Zhike Capsule for postoperative cough after thoracoscopic lung resection in early non-small cell lung cancer
ChiCTR2100050172Phase 4Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of suhuang antitussive capsule in cough and non-small cell lung cancer (NSCLC) (2 arms), sponsored by Peking University People's Hospital. Primary endpoints: Leicester Cough Questionnaire, Cough Symptom Score Table and 8 more. Started Apr 2020; status: recruiting.
02
Drugs
suhuang antitussive capsule
03
Conditions
coughnon-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR2100050172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050172.